I am a passionate diabetes advocate and proud back-of-the-pack runner. I was diagnosed with Type 1 diabetes at 39, a month following my first marathon, which I ran undiagnosed. Twelve marathons later, ...

Why understanding the differences between Type 1 and Type 2 diabetes is essential for better health management and effective ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with type 1 diabetes. The findings counter common assumptions that older adults would ...

Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps ...

Blue Circle Health, a 501(c)(3) nonprofit organization dedicated to improving the health of people with type 1 diabetes (T1D) ...

A recent study published in Diabetes Technology & Therapeutics has demonstrated that the off-label use of semaglutide and ...

Insulin resistance in T1D is more common than you think, and without early intervention, these patients face increased risks ...

Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...

Arti Masturzo, M.D., chief medical officer of CCS, spoke with Managed Healthcare Executive about the differences in coaching ...

TIXiMED Inc. ( a clinical-stage pharmaceutical company based on the breakthrough discovery that TXNIP plays an important role in the ...

This story was excerpted from Maria Guardado’s Giants Beat newsletter. To read the full newsletter, click here. And subscribe ...